Givaudan | GIVN - Operating Expenses

Stock Price
2,814.00
Daily Change
-7.00 -0.25%
Monthly
5.91%
Yearly
-27.38%
Q2 Forecast
2,758.85

Givaudan reported CHF3B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Air Liquide EUR 10.37B 6.15B Dec/2025
Akzo Nobel EUR 2.13B 23M Mar/2026
Anheuser-Busch USD 10.93B 63M Sep/2025
Arkema EUR 2.08B 0 Dec/2025
Associated British Foods GBP 8.85B 275M Jun/2026
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
British American Tobacco GBP 8.54B 1.56B Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Croda International GBP 699.2M 350.7M Dec/2024
Danone EUR 11.68B 239M Dec/2025
Diageo GBP 7.2B 807M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Givaudan CHF 3B 107M Dec/2025
Heineken EUR 12.6B 353M Dec/2025
Henkel EUR 8.67B 122M Dec/2025
International Flavors Fragrances USD 2.48B 11.76B Dec/2025
Johnson Matthey GBP 5.21B 600M Dec/2025
Kerry EUR 2.59B 925.9M Dec/2024
Lonza CHF 2.9B 184M Jun/2025
L'Oréal EUR 17.66B 69.8M Dec/2025
Merck EUR 4.78B 669M Dec/2025
Nestle CHF 38.42B 1.33B Dec/2025
Pernod Ricard EUR 3.64B 174M Dec/2025
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
SGS CHF 1.48B 16.5M Dec/2024
Sika AG CHF 4.8B 78.3M Dec/2025
Solvay EUR 1.03B 24M Dec/2025
Tate & Lyle GBP 895M 63M Dec/2025
Umicore EUR 8.39B 4.03B Jun/2025
Victrex GBP 123.9M 200K Dec/2025